Abstract
To the Editor: In a recent paper1 Scriver et al. stated that in patients with hypophosphatemic bone disease, active rickets is not observed, while serum phosphate is low and the level of 1α,25-dihydroxyvitamin D is normal. On the other hand, in patients with X-linked hypophosphatemia rachitic bone disease is present with similarly low levels of serum phosphate and decreased concentrations of 1α,25-dihydroxyvitamin D. This finding encouraged the authors to believe that a normal level of 1α,25-dihydroxyvitamin D prevents severe bone demineralization or, perhaps better, severe impairment of mineralization. It is possible to agree with this line of thought if the.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 434-435 |
| Number of pages | 2 |
| Journal | New England Journal of Medicine |
| Volume | 300 |
| Issue number | 8 |
| DOIs | |
| State | Published - Feb 22 1979 |
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Serum 1,25-Dihydroxyvitamin D in Bone Disease'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS